The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis

Luca Richeldi, Vincent Cottin, Isabella Annesi-Maesano, Andreas Günther, Liam Galvin, Michael Kreuter, Pippa Powell, Antje Prasse, George Reynolds, Paolo Spagnolo, Claudia Valenzuela, Marlies Wijsenbeek, Wim A. Wuyts, Bruno Crestani

Risultato della ricerca: Contributo in rivistaArticolo in rivista

3 Citazioni (Scopus)

Abstract

Rationale for a multinational registry Idiopathic pulmonary fibrosis (IPF) is the most prevalent of rare pulmonary diseases [1], and the most severe of the chronic forms of idiopathic interstitial pneumonias, with rising incidence and prevalence [2–4]. The prognosis for people diagnosed with IPF is a median survival of 3–3.5 years [1].
Lingua originaleEnglish
pagine (da-a)1-6
Numero di pagine6
RivistaEuropean Respiratory Journal
Volume53
DOI
Stato di pubblicazionePubblicato - 2019

Keywords

  • idiopathic pulmonary fibrosis

Fingerprint Entra nei temi di ricerca di 'The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis'. Insieme formano una fingerprint unica.

Cita questo